BSEShelter Pharma LtdMediumPositive
Announced Wed, 3 Jun · 11:47 IST

Initimation under Regulation 30 of SEBI (LODR) Regulations 2015- Receipt of Good Manufacturing Practices Certificate

Regulatory Product ApprovalBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹31.98
prior close
₹30.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-1.3-1.5-5.7-8.5-6.2-6.2-8.7-7.8-11.2
Up moveDown movePending
AI summary

Shelter Pharma Limited has received a Good Manufacturing Practices (GMP) Certificate from the Food & Drugs Control Administration, Gujarat State. The certificate, bearing Licence No. GA/12, was issued under Form 26-E-1 pursuant to Rule 155-B of the Drugs and Cosmetics Rules, 1945, for the company's manufacturing facility. It covers Ayurvedic formulations including Churna, Tablets, Capsules, Syrups, Oral Liquids, and Ointments, and is valid until October 2030. Management views this as independent validation of the company's quality control systems and manufacturing processes. This is a renewal/continuation of the company's existing GMP compliance certification, not a new approval.

Likely market impact

This is a routine regulatory renewal that confirms continued compliance with manufacturing quality standards, allowing uninterrupted production of Ayurvedic products. It is a positive signal for quality assurance but is unlikely to cause any meaningful movement in the stock price since no new business or revenue is tied to it.